Latest Breaking News On - Meggan mackay - Page 1 : comparemela.com

Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submissi.

United statesSean moranMeggan mackayYuval cohenEuropean association for the study of diabetesNational institute of allergyNational institutes of healthAutoimmune centers of excellenceCorbus pharmaceuticalsCorbus pharmaceuticals holdings incExchange commissionSecurities exchangePrnewswire corbus pharmaceuticals holdings incProgram updatesFeinstein institutes for medical researchPharmaceuticals holdings

Lupus: Five things to know about autoimmune disease triggers

From stress to sunlight to hormones, here are five common factors that can contribute to a flare-up of Lupus symptoms.

New yorkUnited statesAtlantic oceanMeggan mackayAnton shcherbakovPouya shafipourFeinstein institutes for medical research in manhassetLupus foundation of americaNew york cityFort lauderdaleSouth floridaFeinstein institutesMedical researchLupus foundationMenstrual cycleUnited states

Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021

Data to highlight the safety, tolerability and efficacy of LUPKYNIS in patients with lupus nephritis Aurinia Pharmaceuticals Inc. a biopharma company committed to delivering therapeutics that change the course of autoimmune disease, today announced that data from multiple studies of LUPKYNIS™ for the treatment of people with lupus nephritis a serious complication of systemic lupus erythematosus resulting in .

United statesUnited kingdomNeil solomonsMeggan mackayAnca askanaseLindam rehaumeAmit saxenaHanni menn josephyDana lynchSchool of medicineAurinia pharmaceuticals incBoston medical centerAmerican college of rheumatologyColumbia university medical centerFeinstein institute for medical researchAmerican society of nephrology

COVID-19 Vaccine Clinical Trial in People With Autoimmune Disease Starts at Feinstein Institutes

COVID-19 Vaccine Clinical Trial in People With Autoimmune Disease Starts at Feinstein Institutes
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkAnn arborUniversity of pennsylvaniaOklahoma cityLong islandMeggan mackayKevinj traceyRobert cassResearch consortiumNorthwell healthNational institutes of healthNational institute of allergyInstitute of molecular medicineUniversity of michiganOklahoma medical research foundation

NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease

NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease
nih.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nih.gov Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAnn arborUniversity of pennsylvaniaOklahoma cityFrederickgl huetwellMeggan mackayJudith jamesDinesh khannaPaul andersonAnthonys fauciUs department of healthHuman servicesNational institute of allergyNational institutes of healthAutoimmunity centers of excellence